Search
Medpace Holdings Inc
MEDPAdd to Watchlist
460.200USD
+3.110+0.68%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
13.11BMarket Cap
28.37P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Medpace Holdings Inc is 6.71, ranking 326 out of 389 in the Biotechnology & Medical Research industry. The average price target is 567.50, with a high of 655.00 and a low of 302.21.
Analyst Rating
Based on
14
analysts
Hold
Current Rating
440.715
Target Price
-4.23%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Medpace Holdings Inc
MEDP
14
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Medpace Holdings Inc's expected revenue for the next quarter?
Medpace Holdings Inc's expected revenue is 690.07M.
What is Medpace Holdings Inc's price target?
Analysts forecast that Medpace Holdings Inc's price target is USD 567.50, with the highest forecast at USD 655.00 and the lowest forecast at USD 302.21.
How have Medpace Holdings IncMEDP's recent earnings per share performed?
The market expectation was USD 4.35, while Medpace Holdings IncMEDP's earnings per share (EPS) for the previous quarter was USD 4.78. EPS for the next quarter is expected at USD 3.97.
What is the analyst rating for Medpace Holdings Inc?
Based on the ratings of Medpace Holdings Inc's stock from 14 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
